Details

Last Funding Type

Series A

Last Funding Money Raised

$40M

Industries

Health Care,Pharmaceutical

Founded date

Jan 1, 2016

Number Of Employee

251 - 500

Operating Status

Active

Dracen Pharmaceuticals is a developer of novel glutamine antagonists created to deliver improved outcomes for cancer patients and potentially extend the benefits of immuno-oncology therapies. The company develops novel glutamine antagonists with direct anti-tumor apoptotoc properties as well as endogenous anti-tumor immune modulatory mechanisms which increases the number of responders to anti-cancer therapy and extend survival for anti-tumor responses in areas currently evading immuno-oncology approaches.